Challenges and future prospects of antibiotic therapy: from peptides to phages utilization

Santi M Mandal1, Anupam Roy1, Ananta K Ghosh1

  • 1Central Research Facility, Department of Chemistry and Department of Biotechnology, Indian Institute of Technology Kharagpur Kharagpur, India.

Insights

The rise of multi-drug-resistant (MDR) bacterial infections necessitates novel antibiotics. This review explores promising new antimicrobial compounds and therapies to combat these growing global health threats.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Global rise of multi-drug-resistant (MDR) bacterial pathogens poses a significant threat to public health.
  • Decreasing effectiveness of conventional antibiotics is primarily driven by misuse in human and veterinary medicine.
  • Urgent need for novel antimicrobial agents with distinct mechanisms of action against MDR bacteria.

Purpose of the Study:

  • To review current and emerging strategies for discovering next-generation antibiotics.
  • To highlight diverse therapeutic avenues for combating MDR bacterial infections.
  • To provide insights into future research directions for novel antimicrobial compounds.

Main Methods:

  • Comprehensive literature review of recent research on novel antimicrobial strategies.
  • Analysis of various classes of potential antibiotics, including peptides, phages, and small molecules.
  • Examination of therapeutic approaches targeting bacterial resistance mechanisms.

Main Results:

  • Identified several promising avenues for new antibiotic development.
  • Antimicrobial peptides, phage therapy, phytochemicals, metalloantibiotics, and efflux pump inhibitors show potential.
  • Lipopolysaccharide-based strategies also present a novel approach.

Conclusions:

  • A multi-pronged approach combining various novel strategies is crucial for addressing the MDR crisis.
  • Continued research and development are essential to discover and implement effective treatments.
  • Future antibiotics must be safe, effective, and target diverse mechanisms to overcome resistance.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Antibiotic Selection00:57

Antibiotic Selection

Overview
48.9K
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
258
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.4K